Has John Hummel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,390,138 in general payments to John Hummel, MD across 501 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Hummel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Hummel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Hummel, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1356346704

Payments from drug & device makers

$1,390,138in general payments, 2019–2025

Across 501 payments — averaging $2774.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$738K
Volta Medical Inc$225K
Cortex, Inc.$209K
Abbott$95K
Boston Scientific$77K
Atricure, Inc.$17K
plus $29K from 10 others

$2,725in research payments, 2019–2025

Across 4 payments — averaging $681.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$3K

What the payments were for

Consulting fees$69,19025%
Speaking & faculty fees$164,01360%
Travel & lodging$30,41511%
Food & beverage$11,1724%
Education$710%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	307	$737,761
Volta Medical Inc	49	$225,385
Cortex, Inc.	2	$209,298
Abbott	88	$95,030
Boston Scientific	12	$76,913
Atricure, Inc.	10	$17,044
Biosense Webster, Inc.	14	$13,764
Medical Device Business Services, Inc.	5	$6,542
Philips North America LLC	4	$4,444
Baylis Medical Company Inc	1	$2,019
EBR Systems, Inc.	2	$1,127
Altathera Pharmaceuticals LLC	2	$393
Ablacon, Inc.	2	$266
Acutus Medical, Inc.	1	$102
Catheter Precision Inc.	1	$34
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$118,560
VX1$32,094
TACTICATH$11,871
Carto 3 System$10,380
TACTICATH ABLATION CATHETER, SENSOR ENABLED$5,525
Spectranetics Undiv$3,750
Carto 3$3,175
Carto Smarttouch$3,150
Carto CFAE$3,150
CartoSound$3,150
Arctic Front$2,345
VersaCross Access Solution$2,019
AVEIR$1,637
AMPLATZER Occluders$1,400
TactiCath Quartz CFA Catheter$1,399
CARDIOBLATE CRYOFLEX$1,043
AMPLATZER AMULET$974
EVERA MRI XT DR SURESCAN$795
EPD Solutions Und$600
Ensite Cardiac Mapping System$590

How this compares

$1,390,138 in reported general payments places this provider in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$212,465

Medicare patients

1,017

Services billed

1,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	362	$407,139
XareltoRivaroxaban	55	$63,502
Dofetilide	151	$37,202
Mexiletine Hcl	61	$10,480
Amiodarone Hcl	192	$5,113
Metoprolol Succinate	174	$2,165
Diltiazem 24hr Er (Cd)Diltiazem Hcl	91	$2,158
Flecainide Acetate	37	$1,891
SotalolSotalol Hcl	127	$1,766
Clonidine	15	$816
Potassium Chloride	33	$690
Atenolol	37	$601
Klor-Con M20Potassium Chloride	22	$565
Carvedilol	50	$376
Nebivolol Hcl	11	$275

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Columbus

Anish AminColumbus$2.8M
Auroa BadinColumbus$580K
Ralph AugostiniColumbus$552K
Sreedhar BillakantyColumbus$458K
Mahmoud HoumsseColumbus$319K
Salvatore SavonaColumbus$249K
Eugene FuColumbus$214K
Jaret TylerColumbus$185K
Francis HackettColumbus$153K
David NemerColumbus$97K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →